Latest News

Recent reports highlight Chalice Mining’s Gonneville palladium-nickel-copper project in Western Australia, which the company says could materially influence global palladium supply and is currently planned for a two-stage development with A$820 million in initial capital expenditure, largely funded by debt, following anticipated regulatory approvals in early 2028. At the same time, Managing Director Alexander Carl Dorsch’s sale of 1.5 million shares at A$2.30 each has sharpened market focus...

Regeneron Pharmaceuticals (REGN) is back in focus after the approval of its high dose Eylea HD, which cuts injection frequency, combined with continued Dupixent momentum and fresh bullish commentary from analysts and long term shareholders. See our latest analysis for Regeneron Pharmaceuticals. Those Eylea HD and Dupixent updates arrive as Regeneron’s 90 day share price return of 15.14% contrasts with a softer year to date share price return of a 2.93% decline, while the 1 year total...

Arrowhead Pharmaceuticals (ARWR) has drawn fresh attention after China’s NMPA approved its drug Redemplo for familial chylomicronemia syndrome. This marks the therapy’s third clearance, following earlier approvals in the US and Canada. See our latest analysis for Arrowhead Pharmaceuticals. At a share price of US$67.05, Arrowhead has given investors a 69.53% 90 day share price return. The 1 year total shareholder return of 231.11% and 3 year total shareholder return of 101.47% underline how...

On January 22, 2026, Eastern Bankshares reported Q4 2025 earnings that exceeded analyst expectations, detailed higher full-year net interest income of US$828.6 million, and confirmed a regular quarterly cash dividend of US$0.13 per share payable on March 20, 2026 to shareholders of record on March 6, 2026. The company also completed a US$55.4 million buyback of 3,100,000 shares, reported lower net charge-offs of US$9.8 million for Q4 2025, and highlighted record wealth assets under...

Lingbao Gold Group has appointed corporate law expert Mr. Huang Hui as an independent non-executive director and committee chair, and shareholders have approved amendments to the company’s Articles of Association at an extraordinary general meeting held on 22 January 2026. This combination of governance-focused board refresh and updated Articles signals an increased emphasis on oversight, legal expertise, and rule-setting at the top of the company. We’ll now examine how the appointment of...

L3Harris Technologies has raised its quarterly cash dividend from US$1.20 to US$1.25 per share, and the Pentagon has committed US$1.00 billion to its solid rocket motors business ahead of a planned Missile Solutions spin-off and IPO in the second half of 2026. Together, the higher dividend and the Department of Defense’s direct equity stake highlight L3Harris’s effort to reposition its portfolio around core defense technologies while still emphasizing shareholder returns. We’ll now examine...

Fidelity National Information Services (FIS) recently reshaped its business mix by selling its remaining Worldpay stake and buying Global Payments' issuer solutions arm, while lifting its 2025 revenue and earnings guidance to reflect operational progress. See our latest analysis for Fidelity National Information Services. Even after the recent portfolio reshuffle and upgraded 2025 guidance, the 1-year total shareholder return of 23.71% decline and 5-year total shareholder return of 47.69%...

United Airlines Holdings reported its fourth-quarter 2025 results, with revenue of US$15,397 million and net income of US$1,044 million, alongside record full-year revenue of US$59,070 million and earnings per share of US$10.20. Beyond the headline records, the company’s premium cabins delivered around 12% year-on-year revenue growth, and United became the only US airline to grow earnings per share over the year while also raising guidance for 2026. We’ll now examine how United’s upgraded...

In January 2026, IPG Photonics showcased a broad lineup of new laser solutions at the SPIE Photonics West Exhibition in San Francisco, spanning cleaning, welding, cutting, micro‑machining, semiconductor manufacturing, and directed energy applications. The introduction of ultra‑compact multi‑kilowatt lasers, deep UV and femtosecond sources, and integrated high‑power welding platforms underscores IPG Photonics’ push into higher‑precision manufacturing, defense, and EV battery production...

Why the recent news around West Pharmaceutical Services stock matters West Pharmaceutical Services (WST) has been in focus after recent commentary highlighted expected improvements in earnings estimates, a positive Zacks ranking, and solid demand for its proprietary drug delivery products and capacity expansion plans. See our latest analysis for West Pharmaceutical Services. Despite upbeat commentary around earnings estimates and strong demand for its drug delivery products, the share price...

Index inclusion puts Genesis Minerals in sharper focus Genesis Minerals (ASX:GMD) has been added to the ASX 200 index, a shift that immediately puts the gold producer on the radar of index funds and more institutional investors. This change can affect trading volumes, liquidity and how Genesis Minerals fits into diversified Australian equity portfolios. It may prompt many investors to reassess its A$7.86 share price, recent returns and fundamentals. See our latest analysis for Genesis...

Pursuit Attractions and Hospitality, Inc. previously announced it had entered into an agreement to sell its Flyover flying theater subsidiaries for US$78.40 million in cash, subject to regulatory approvals and including a US$10.00 million termination fee under certain conditions. This divestiture marks a meaningful reshaping of Pursuit’s attractions portfolio and signals potential capital redeployment within its wider hospitality and attractions businesses. We will now examine how the...

Readers hoping to buy Kirloskar Pneumatic Company Limited ( NSE:KIRLPNU ) for its dividend will need to make their move...

It looks like Advani Hotels & Resorts (India) Limited ( NSE:ADVANIHOTR ) is about to go ex-dividend in the next three...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Typically...

As Saudi Arabia's stock market gains momentum ahead of upcoming earnings and the anticipated opening to foreign investors, the Middle East is poised for increased attention from global capital. This evolving landscape presents a fertile ground for identifying promising stocks, where strong fundamentals and strategic positioning can offer potential opportunities amidst rising investor interest.

Most readers would already be aware that Grupa Klepsydra's (WSE:KLE) stock increased significantly by 23% over the past...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Amongst other things, we'll want to...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...

Thyrocare Technologies (NSE:THYROCARE) has had a rough week with its share price down 7.5%. It is possible that the...

Key Insights LT Foods' estimated fair value is ₹338 based on 2 Stage Free Cash Flow to Equity Current share price of...

Preliminary 2025 loss guidance and recent share move JinkoSolar Holding (JKS) recently issued preliminary unaudited 2025 earnings guidance, indicating an estimated net loss for Jiangxi Jinko of RMB 5,900 million to RMB 6,900 million, with losses remaining sizeable even after excluding extraordinary items. The guidance followed a volatile stretch for the stock, including a decline over the past week following gains over the past 3 months. It provides investors with a clearer fundamental...

In January 2026, Guardian Pharmacy Services, Inc. reaffirmed its 2025 revenue guidance of US$1.43 billion to US$1.45 billion and issued new 2026 guidance of US$1.40 billion to US$1.42 billion. This updated outlook gives investors a clearer view of expected near-term revenue trends and reflects management’s willingness to quantify its forward plans. Next, we’ll examine how the reaffirmed 2025 outlook and newly issued 2026 revenue range shape Guardian Pharmacy Services’ investment...